Literature DB >> 20373370

Hepatobiliary complications of hematopoietic cell transplantation, 40 years on.

George B McDonald1.   

Abstract

Liver problems caused by infection, cholestasis and sinusoidal liver injury in the months following HCT have become less frequent because of preventive and pre-emptive strategies. When patients develop jaundice after transplant, the time to search for treatable causes is early in the course of jaundice, as the risk of mortality rises steeply with small increments of serum bilirubin above normal. Chronic hepatitis C, persistent GVHD, cirrhosis and hepatocellular carcinoma are significant liver problems in the longest-lived survivors of HCT.

Entities:  

Mesh:

Year:  2010        PMID: 20373370      PMCID: PMC2914093          DOI: 10.1002/hep.23533

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  46 in total

1.  Activation of occult hepatitis B from a seronegative patient after hematopoietic cell transplant: a cautionary tale.

Authors:  Paul A Carpenter; Meei-Li Huang; George B McDonald
Journal:  Blood       Date:  2002-06-01       Impact factor: 22.113

2.  Chronic graft-versus-host disease of the liver: presentation as an acute hepatitis.

Authors:  S I Strasser; H M Shulman; M E Flowers; R Reddy; D A Margolis; M Prumbaum; S E Seropian; G B McDonald
Journal:  Hepatology       Date:  2000-12       Impact factor: 17.425

3.  Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation.

Authors:  George B McDonald; John T Slattery; Michelle E Bouvier; Song Ren; Ami L Batchelder; Thomas F Kalhorn; H Gary Schoch; Claudio Anasetti; Ted Gooley
Journal:  Blood       Date:  2002-10-24       Impact factor: 22.113

Review 4.  Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease).

Authors:  Laurie D DeLeve; Howard M Shulman; George B McDonald
Journal:  Semin Liver Dis       Date:  2002-02       Impact factor: 6.115

5.  Hyperammonemia after high-dose chemotherapy and stem cell transplantation.

Authors:  P Frere; J L Canivet; C Gennigens; J P Rebeix; G Fillet; Y Beguin
Journal:  Bone Marrow Transplant       Date:  2000-08       Impact factor: 5.483

6.  Role of oxidative stress and glutathione in busulfan toxicity in cultured murine hepatocytes.

Authors:  L D DeLeve; X Wang
Journal:  Pharmacology       Date:  2000-04       Impact factor: 2.547

7.  Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen.

Authors:  George K K Lau; Deepak Suri; Raymond Liang; Eirini I Rigopoulou; Mark G Thomas; Ivana Mullerova; Amin Nanji; Siu-Tsan Yuen; Roger Williams; Nikolai V Naoumov
Journal:  Gastroenterology       Date:  2002-03       Impact factor: 22.682

8.  Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial.

Authors:  Paul G Richardson; Robert J Soiffer; Joseph H Antin; Hajime Uno; Zhezhen Jin; Joanne Kurtzberg; Paul L Martin; Gideon Steinbach; Karen F Murray; Georgia B Vogelsang; Allen R Chen; Amrita Krishnan; Nancy A Kernan; David E Avigan; Thomas R Spitzer; Howard M Shulman; Donald N Di Salvo; Carolyn Revta; Diane Warren; Parisa Momtaz; Gary Bradwin; L J Wei; Massimo Iacobelli; George B McDonald; Eva C Guinan
Journal:  Biol Blood Marrow Transplant       Date:  2010-02-16       Impact factor: 5.742

9.  Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation.

Authors:  Tapani Ruutu; Britta Eriksson; Kari Remes; Eeva Juvonen; Liisa Volin; Mats Remberger; Terttu Parkkali; Hans Hägglund; Olle Ringdén
Journal:  Blood       Date:  2002-09-15       Impact factor: 22.113

10.  Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients.

Authors:  William J Hogan; Michael Maris; Barry Storer; Brenda M Sandmaier; David G Maloney; H Gary Schoch; Ann E Woolfrey; Howard M Shulman; Rainer Storb; George B McDonald
Journal:  Blood       Date:  2003-09-11       Impact factor: 22.113

View more
  48 in total

Review 1.  Acute kidney injury in hematopoietic cell transplantation.

Authors:  Amy Kogon; Sangeeta Hingorani
Journal:  Semin Nephrol       Date:  2010-11       Impact factor: 5.299

Review 2.  Onco-nephrology: AKI in the cancer patient.

Authors:  Albert Q Lam; Benjamin D Humphreys
Journal:  Clin J Am Soc Nephrol       Date:  2012-08-09       Impact factor: 8.237

Review 3.  Acute graft-versus-host disease of the gut: considerations for the gastroenterologist.

Authors:  Steven Naymagon; Leonard Naymagon; Serre-Yu Wong; Huaibin Mabel Ko; Anne Renteria; John Levine; Jean-Frederic Colombel; James Ferrara
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-09-27       Impact factor: 46.802

4.  Lessons learned from the investigational device exemption review of Children's Oncology Group trial AAML1031.

Authors:  Soheil Meshinchi; Stephen P Hunger; Richard Aplenc; Peter C Adamson; J Milburn Jessup
Journal:  Clin Cancer Res       Date:  2012-03-15       Impact factor: 12.531

5.  Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabine.

Authors:  Andrew C Harris; Jaap J Boelens; Kwang Woo Ahn; Mingwei Fei; Allistair Abraham; Andrew Artz; Christopher Dvorak; Haydar Frangoul; Cesar Freytes; Robert Peter Gale; Sanghee Hong; Hillard M Lazarus; Alison Loren; Shin Mineishi; Taiga Nishihori; Tracey O'Brien; Kirsten Williams; Marcelo C Pasquini; John E Levine
Journal:  Blood Adv       Date:  2018-06-12

6.  Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.

Authors:  N S Majhail; J D Rizzo; S J Lee; M Aljurf; Y Atsuta; C Bonfim; L J Burns; N Chaudhri; S Davies; S Okamoto; A Seber; G Socie; J Szer; M T Van Lint; J R Wingard; A Tichelli
Journal:  Hematol Oncol Stem Cell Ther       Date:  2012

7.  Mice engrafted with human fetal thymic tissue and hematopoietic stem cells develop pathology resembling chronic graft-versus-host disease.

Authors:  Jennifer L Lockridge; Ying Zhou; Yusof A Becker; Shidong Ma; Shannon C Kenney; Peiman Hematti; Christian M Capitini; William J Burlingham; Annette Gendron-Fitzpatrick; Jenny E Gumperz
Journal:  Biol Blood Marrow Transplant       Date:  2013-06-24       Impact factor: 5.742

8.  Value of liver elastography and abdominal ultrasound for detection of complications of allogeneic hemopoietic SCT.

Authors:  T Karlas; J Weber; C Nehring; R Kronenberger; H Tenckhoff; J Mössner; D Niederwieser; M Tröltzsch; T Lange; V Keim
Journal:  Bone Marrow Transplant       Date:  2014-04-07       Impact factor: 5.483

Review 9.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report.

Authors:  Juan Gea-Banacloche; Krishna V Komanduri; Paul Carpenter; Sophie Paczesny; Stefanie Sarantopoulos; Jo-Anne Young; Nahed El Kassar; Robert Q Le; Kirk R Schultz; Linda M Griffith; Bipin N Savani; John R Wingard
Journal:  Biol Blood Marrow Transplant       Date:  2016-10-14       Impact factor: 5.742

10.  How I treat hepatitis C virus infection in patients with hematologic malignancies.

Authors:  Harrys A Torres; George B McDonald
Journal:  Blood       Date:  2016-07-21       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.